Drug cos against move to rationalise trade margins on patented products

The representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domestic pharma representatives that run PAP programmes, will meet minister of health and family Mansukh Mandaviya and officials from department of pharmaceutical (DoP), National Pharmaceutical Pricing Authority (NPPA) on Monday to discuss the issue regarding TMR on PAP drugs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zHN8Mqc
via IFTTT